Thinking in three dimensions: A web-based algorithm to aid the interpretation of tuberculin skin test results

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 5, 2008, Pages 498-505

  Menzies, Dick ^a   Gardiner, G ^a,b   Farhat, M ^a,b   Greenaway, C ^a,c   Pai, M ^a,d  

^a MCGILL UNIVERSITY   (Canada)

^b HARVARD UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Clinical decision aids; Latent TB infection; Prediction rules; Software; Tuberculin skin test

Indexed keywords

ALGORITHM; ARTICLE; BCG VACCINATION; COMPUTER PROGRAM; HUMAN; INFANCY; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NEWBORN; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; RADIOGRAPHY; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ALGORITHMS; BCG VACCINE; DECISION SUPPORT TECHNIQUES; HUMANS; INTERNET; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SOFTWARE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 43949107191     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Menzies D, Pai M, Comstock G W. New tests for diagnosis of latent tuberculosis infection - areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
2. Mazurek G, Jereb J, LoBue P, et al. Guidelines for the investigation of contacts of persons with infectious tuberculosis - recommendations from the National Tuberculosis Controllers Association and CDC - guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb Mortal Wkly Rep 2005; 54 [RR-15]: 49-55.
3. Royal College of Physicians. Tuberculosis: national clinical guidelines for diagnosis, management, prevention and control. London, UK: Royal College of Physicians, 2006.
4. Canadian Tuberculosis Committee. Interferon-gamma release assays for latent tuberculosis infection (an advisory committee statement). Canada Communicable Disease Report 2007; 33: 1-18.
5. Rieder H L. Epidemiologic basis of tuberculosis control. Paris, France: International Union Against Tuberculosis and Lung Disease, 1999.
6. Karakousis P C, Sifakis F G, De Oca R M, et al. US medical resident familiarity with national tuberculosis guidelines. BMC Infect Dis 2007; 7: 89.
7. Steele A W, Eisert S, Davidson A, et al. Using computerized clinical decision support for latent tuberculosis infection screening. Am J Prev Med 2005; 28: 281.
8. Chertow G M, Lee J, Kuperman G J, et al. Guided medication dosing for in-patients with renal insufficiency. JAMA 2001; 286: 2839-2844.
9. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests - what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1-13.
10. Long R. Canadian Tuberculosis Standards. 6th ed. Ottawa, Canada: Canadian Lung Association, Public Health Agency of Canada, 2007.
11. Styblo K. The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc Lung Dis 1985; 60 (3-4): 117-119.
12. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2004. WHO/HTM/TB/2004.331. Geneva, Switzerland: WHO, 2004.
13. Van Zwanenberg D. The influence of the number of bacilli on the development of tuberculous disease in children. Am Rev Respir Dis 1960; 82: 31-44.
14. Grzybowski S, Barnett G D, Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc Lung Dis 1975; 50 (1): 90-106.
15. Van Geuns H A, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967-1969. Bull Int Union Tuberc Lung Dis 1975; 50 (1): 107-121.
16. Karalus N C. Contact screening procedures for tuberculosis in Auckland. N Z Med J 1988; 101: 45-49.
17. Zaki M H, Lyons H A, Robins A B, Brown E P. Tuberculin sensitivity. NY State J Med 1976; 76: 2138-2143.
18. Greenaway C, Palayew M, Menzies D. Yield of casual contact investigation by the hour. Int J Tuberc Lung Dis 2003; 7 (Suppl 3): S479-S485.
19. Palmer C E, Edwards L B, Hopwood L, Edwards P Q. Experimental and epidemiologic basis for the interpretation of tuberculin sensitivity. J Pediatrics 1959; 55: 413-428.
20. Palmer C E, Edwards L B. Identifying the tuberculous infected. The dual-test technique. JAMA 1968; 205: 167-169.
21. Edwards L B, Acquaviva F A, Livesay V T. Identification of tuberculous infected: dual tests and density of reaction. Am Rev Respir Dis 1973; 108: 1334-1339.
22. Comstock G W, Edwards L B, Livesay V T. Tuberculosis morbidity in the US Navy: its distribution and decline. Am Rev Respir Dis 1974; 110: 572-580.
23. Long R. Canadian tuberculosis standards. Toronto, Canada: Canadian Lung Association, 2000.
24. Horwitz O, Wilbek E, Erickson P A. Epidemiological basis of tuberculosis eradication. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area. Bull World Health Organ 1969; 41: 95-113.
25. Grzybowski S, Fishaut H, Rowe J, Brown A. Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am Rev Respir Dis 1971; 104: 605-608.
26. Maurya V, Vijayan V K, Shah A. Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis 2002; 6: 942-951.
27. Comstock G W. Frost revisited: the modern epidemiology of tuberculosis. Am J Epidemiol 1975; 101: 363-382.
28. Kim S J, Hong Y P, Lew W J, Yang S C, Lee E G. Incidence of pulmonary tuberculosis among diabetics. Tubercle Lung Dis 1995; 76: 529-533.
29. Silwer H, Oscarsson P N. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand 1958; 161: 1-48.
30. Pablos-Mendez A, Blustein J, Knirsch C A. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87: 574-579.
31. Boucot K R. Diabetes mellitus and pulmonary tuberculosis. J Chronic Dis 1957; 6: 256-279.
32. Keane J, Gershon S, Wise R P, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098-1104.
33. Nolan C M, Elarth A M. Tuberculosis in a cohort of South-east Asian refugees: a five-year surveillance study. Am Rev Respir Dis 1988; 137: 805-809.
34. Grzybowksi S, McKinnon N E, Tuters L, Pinkus G, Philipps R. Reactivations in inactive pulmonary tuberculosis. Am Rev Respir Dis 1966; 93: 352-360.
35. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63.
36. Sutherland I. The evolution of clinical tuberculosis in adolescents. Tubercle 1966; 47: 308.
37. Rieder H L, Cauthen G M, Comstock G W, Snider D E Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989; 11: 79-98.
38. Malhotra K K, Parashar M K, Sharma R K, et al. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981; 57: 492-498.
39. Lundin A P, Adler A J, Berlyne G M, Friedman E A. Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 1979; 67: 597-602.
40. Andrew O T, Schoenfeld P Y, Hopewell P C, Humphreys M H. Tuberculosis in patients with end-stage renal disease. Am J Med 1980; 68: 59-65.
41. Pradhan R P, Katz L A, Nidus B D, Matalon R, Eisinger R P. Tuberculosis in dialyzed patients. JAMA 1974; 229: 798-800.
42. Hong Kong Chest Service Tuberculosis Research Centre MB-MRC. A double-blind placebo-controlled clinical trial of three anti-tuberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145: 36-41.
43. Cowie R L. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 1994; 150: 1460-1462.
44. Antonucci G, Girardi E, Raviglione M C, Ippolito G, for the GISTA. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. JAMA 1995; 274: 143-148.
45. Guelar A, Gatell J M, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-1349.
46. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
47. Wood R, Maartens G, Lombard C J. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23: 75-80.
48. Sakhuja V, Jha V, Varma P P, Joshi K, Chugh K S. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
49. Aguado J M, Herrero J A, Gavalda J, et al. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation 1997; 63: 1278-1286.
50. Miller R A, Lanza L A, Kline J N, Geist L J. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995; 152: 374-376.
51. Meyers B R, Halpern M, Sheiner P, Mendelson M H, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994; 58: 301-306.
52. Horsburgh C R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060.
53. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161 (Suppl): S221-S247.
54. Behr M A, Warren S A, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative from acid-fast bacilli. Lancet 1999; 353: 444-449.
55. Page K R, Chaisson R E. Tuberculosis - HIV co-infection: epidemiology, clinical aspects and interventions. In: Raviglione M C, ed. Reichman and Hershfield's tuberculosis: a comprehensive, international approach. 3rd ed. New York, NY, USA: Informa Healthcare USA, 2006: 2 vols: pp 371-416.
56. Cobelens F G. False positive tuberculin reactions due to non-tuberculous mycobacterial infections [Letter]. Int J Tuberc Lung Dis 2007; 11: 934-935.